Ulbrich K - Search Results

1

HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity.

Ulbrich K, Etrych T, Chytil P, Jelínková M, Ríhová B. Ulbrich K, et al. J Control Release. 2003 Feb 21;87(1-3):33-47. doi: 10.1016/s0168-3659(02)00348-6. J Control Release. 2003. PMID: 12618021

2

Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.

Kovár M, Strohalm J, Etrych T, Ulbrich K, Ríhová B. Kovár M, et al. Among authors: ulbrich k. Bioconjug Chem. 2002 Mar-Apr;13(2):206-15. doi: 10.1021/bc010063m. Bioconjug Chem. 2002. PMID: 11906257

3

HPMA-hydrogels containing cytostatic drugs. Kinetics of the drug release and in vivo efficacy.

St'astný M, Plocová D, Etrych T, Kovár M, Ulbrich K, Ríhová B. St'astný M, et al. Among authors: ulbrich k. J Control Release. 2002 May 17;81(1-2):101-11. doi: 10.1016/s0168-3659(02)00047-0. J Control Release. 2002. PMID: 11992683

4

Cytostatic and immunomobilizing activities of polymer-bound drugs: experimental and first clinical data.

Ríhová B, Strohalm J, Prausová J, Kubácková K, Jelínková M, Rozprimová L, Sírová M, Plocová D, Etrych T, Subr V, Mrkvan T, Kovár M, Ulbrich K. Ríhová B, et al. Among authors: ulbrich k. J Control Release. 2003 Aug 28;91(1-2):1-16. doi: 10.1016/s0168-3659(03)00235-9. J Control Release. 2003. PMID: 12932633

5

Starlike vs. classic macromolecular prodrugs: two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs.

Jelínková M, Strohalm J, Etrych T, Ulbrich K, Ríhová B. Jelínková M, et al. Among authors: ulbrich k. Pharm Res. 2003 Oct;20(10):1558-64. doi: 10.1023/a:1026170830782. Pharm Res. 2003. PMID: 14620507

6

Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity.

Mrkvan T, Sirova M, Etrych T, Chytil P, Strohalm J, Plocova D, Ulbrich K, Rihova B. Mrkvan T, et al. Among authors: ulbrich k. J Control Release. 2005 Dec 10;110(1):119-29. doi: 10.1016/j.jconrel.2005.09.028. Epub 2005 Nov 2. J Control Release. 2005. PMID: 16269198

7

Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification.

Chytil P, Etrych T, Konák C, Sírová M, Mrkvan T, Ríhová B, Ulbrich K. Chytil P, et al. Among authors: ulbrich k. J Control Release. 2006 Sep 28;115(1):26-36. doi: 10.1016/j.jconrel.2006.06.028. Epub 2006 Jun 30. J Control Release. 2006. PMID: 16899320

8

Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy.

Etrych T, Mrkvan T, Ríhová B, Ulbrich K. Etrych T, et al. Among authors: ulbrich k. J Control Release. 2007 Sep 11;122(1):31-8. doi: 10.1016/j.jconrel.2007.06.007. Epub 2007 Jun 16. J Control Release. 2007. PMID: 17631976

9

Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting.

Etrych T, Chytil P, Mrkvan T, Sírová M, Ríhová B, Ulbrich K. Etrych T, et al. Among authors: ulbrich k. J Control Release. 2008 Dec 18;132(3):184-92. doi: 10.1016/j.jconrel.2008.04.017. Epub 2008 Apr 29. J Control Release. 2008. PMID: 18534705

10

HPMA-based polymer conjugates with drug combination.

Krakovicová H, Etrych T, Ulbrich K. Krakovicová H, et al. Among authors: ulbrich k. Eur J Pharm Sci. 2009 Jun 28;37(3-4):405-12. doi: 10.1016/j.ejps.2009.03.011. Epub 2009 Apr 1. Eur J Pharm Sci. 2009. PMID: 19491032

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters